AustinPx Live Episode 2: Navigating Complexity: Tailored Analytical & Preclinical Services

In the second session of AustinPx Live, Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx designs data-driven, early-phase strategies to solve complex drug development challenges. He’ll highlight our tailored analytical services, preclinical expertise, and how they connect with our broader CDMO model. This 30-minute session includes a 20-minute presentation followed by live Q&A.